Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Status:
Recruiting
Trial end date:
2022-11-23
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether taking either of two low dose
drugs that would prevent new blood vessels from growing after stem cell transplant is
feasible, and what the side effects of taking each of these drugs after autologous transplant
might be. The reason the investigators are looking at these drugs is because one of the
things that allows tumors to grow quickly is their ability to stimulate the growth of new
blood vessels. By suppressing the growth of new blood vessels after stem cell transplant, the
investigators hope to prevent the tumors from coming back or continuing to grow.